JP2022515226A5 - - Google Patents

Info

Publication number
JP2022515226A5
JP2022515226A5 JP2021536271A JP2021536271A JP2022515226A5 JP 2022515226 A5 JP2022515226 A5 JP 2022515226A5 JP 2021536271 A JP2021536271 A JP 2021536271A JP 2021536271 A JP2021536271 A JP 2021536271A JP 2022515226 A5 JP2022515226 A5 JP 2022515226A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
seq
binding fragment
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021536271A
Other languages
English (en)
Japanese (ja)
Other versions
JP7614647B2 (ja
JP2022515226A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/067874 external-priority patent/WO2020132456A1/en
Publication of JP2022515226A publication Critical patent/JP2022515226A/ja
Publication of JP2022515226A5 publication Critical patent/JP2022515226A5/ja
Application granted granted Critical
Publication of JP7614647B2 publication Critical patent/JP7614647B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021536271A 2018-12-20 2019-12-20 １型糖尿病、その他の自己免疫疾患の処置 Active JP7614647B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201862782646P 2018-12-20 2018-12-20
US201862782624P 2018-12-20 2018-12-20
US62/782,646 2018-12-20
US62/782,624 2018-12-20
US201962854289P 2019-05-29 2019-05-29
US201962854286P 2019-05-29 2019-05-29
US62/854,289 2019-05-29
US62/854,286 2019-05-29
PCT/US2019/067874 WO2020132456A1 (en) 2018-12-20 2019-12-20 Treating type 1 diabetes, other autoimmune diseases

Publications (3)

Publication Number Publication Date
JP2022515226A JP2022515226A (ja) 2022-02-17
JP2022515226A5 true JP2022515226A5 (cg-RX-API-DMAC7.html) 2023-01-11
JP7614647B2 JP7614647B2 (ja) 2025-01-16

Family

ID=71101601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021536271A Active JP7614647B2 (ja) 2018-12-20 2019-12-20 １型糖尿病、その他の自己免疫疾患の処置

Country Status (4)

Country Link
US (1) US20220073963A1 (cg-RX-API-DMAC7.html)
EP (1) EP3899039A4 (cg-RX-API-DMAC7.html)
JP (1) JP7614647B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020132456A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005219876A1 (en) * 2004-03-01 2005-09-15 Peptimmune, Inc. Methods and compositions for treatment of autoimmune diseases
MX2008014978A (es) * 2006-06-06 2008-12-09 Crucell Holland Bv Moleculas de union humanas que tienen actividad exterminadora contra enterococos y staphylococcus aureus y usos de las mismas.
GB2444410B (en) * 2006-11-30 2011-08-24 Navigenics Inc Genetic analysis systems and methods
EP2567226B1 (en) * 2010-05-06 2016-08-10 Adaptive Biotechnologies Corporation Monitoring health and disease status using clonotype profiles
WO2015162124A1 (en) * 2014-04-22 2015-10-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnostic of an autoimmune disease
WO2016100615A2 (en) * 2014-12-18 2016-06-23 The University Of Chicago Methods and composition for neutralization of influenza

Similar Documents

Publication Publication Date Title
CN111778218B (zh) 噬菌体展示抗体库及基于其淘筛获得的针对新冠病毒SARS-CoV-2的单克隆抗体
US20220206001A1 (en) Methods and systems for detecting coronavirus
JP2017513937A5 (cg-RX-API-DMAC7.html)
CN104995517B (zh) 复合物特异性抗体和抗体片段及其用途
US12134656B2 (en) Dickkopf-1 variant antibodies and methods of use
JP2015504430A5 (cg-RX-API-DMAC7.html)
JP2020529830A5 (cg-RX-API-DMAC7.html)
TW201024731A (en) Improved methods of RNA display
RU2016144177A (ru) Способы избирательного лечения астмы с использованием антагонистов il-13
JP2016516400A5 (cg-RX-API-DMAC7.html)
EP4466284A2 (en) Multispecific sars-cov-2 antibodies and methods of use
WO2022061594A1 (zh) 新型冠状病毒（sars-cov-2）刺突蛋白结合分子及其应用
CN116249710A (zh) 治疗性抗体
JP2018535922A (ja) 抗Ｎ−メチル−Ｄ−アスパラギン酸（ＮＭＤＡ）受容体抗体の結合領域に結合する抗体または抗体フラグメントまたは非Ｉｇ足場
CN119798445B (zh) 一种抗nkg2d纳米抗体及其制备方法与应用
CA3177550A1 (en) Bispecific molecules for selectively modulating t cells
JP2023518225A5 (cg-RX-API-DMAC7.html)
JP2017536821A5 (cg-RX-API-DMAC7.html)
JP2022538688A5 (cg-RX-API-DMAC7.html)
CN113621065B (zh) 靶向4-1bb的全人源抗体及其制备方法和应用
JP2022515226A5 (cg-RX-API-DMAC7.html)
JP2020515286A5 (cg-RX-API-DMAC7.html)
CN118085082A (zh) 抗猫TNF-α单克隆抗体及其应用
JP2021501589A5 (cg-RX-API-DMAC7.html)
JP2024539079A5 (cg-RX-API-DMAC7.html)